Morgan's February 2026 global research report projects a $3055 billion annual revenue reduction for the food and beverage industry by 20302034, attributable directly to GLP-1 adoption
Reviews 1,393 4.6 HSA/FSA Weight Loss A next-generation compounded GLP-1/GIP injection with tirzepatide, combining dual pathways for appetite regulation and metabolic improvement, designed to support significant progress in weight care and health goals
It can be jarring for some, but we believe that part of normalizing GLP-1s-as-healthcare starts with demystifying what the experience is really like
Otherwise, I dont know who's fighting for them and getting them access. Burgin, on the other hand, believes states should focus on setting clear expectations and promoting personal responsibility
Employers generally decide what to cover, within rules such as the ACA and MHPAEA